Webinar: How to Profit from Recent Innovations in Small Molecule Drug Discovery
With small molecules making up over 60% of new drug approvals in 2021, it’s clear that the appetite for progression and potential for innovation is huge. The renaissance of small molecule drug discovery means one thing for certain: the race to explore uncharted biologically active chemical space is on.
During this one-hour webinar with Dotmatics’ Director of product marketing Haydn Boehm, we’ll explore the current landscape and how things sit with small and large molecule research. Haydn will also outline the friction points scientists may encounter in the small molecule drug discovery process.
By attending this webinar, you will learn:
Why research collaboration is vitally important for all scientists working in this field
How to get the most out of data from multiple sources, by efficiently merging and managing all available data, wherever it comes from
To optimise your workflow in accordance with your specific needs, ultimately improving cycle times, reducing costs and finding better candidates as quickly as possible